Chemoinformaics analysis of (E)-2-METHYL-7-(4-METHYLPHENYL)HEPT-2-EN-1-OL
| Molecular Weight | 218.34 | nRot | 6 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 43 |
| Exact Molecular Weight | 218.167 | nRing | 1 |
| Solubility: LogS | -5.846 | nHRing | 0 |
| Solubility: LogP | 5.543 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.212 |
| Synth | 5.602 |
| Natural Product Likeliness | 1.488 |
| NR-PPAR-gamma | 0.03 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.985 |
| Pgp-sub | 0.56 |
| HIA | 0.015 |
| CACO-2 | -5.501 |
| MDCK | 0.0000324 |
| BBB | 0.027 |
| PPB | 0.847504 |
| VDSS | 0.458 |
| FU | 0.116168 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.979 |
| CYP2c19-inh | 0.227 |
| CYP2c19-sub | 0.849 |
| CYP2c9-inh | 0.293 |
| CYP2c9-sub | 0.794 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.903 |
| CYP3a4-inh | 0.217 |
| CYP3a4-sub | 0.942 |
| CL | 6.889 |
| T12 | 0.232 |
| hERG | 0.912 |
| Ames | 0.215 |
| ROA | 0.893 |
| SkinSen | 0.452 |
| Carcinogencity | 0.055 |
| EI | 0.006 |
| Respiratory | 0.694 |
| NR-Aromatase | 0.552 |
| Antiviral | Yes |
| Prediction | 0.811781 |